Crescent Biopharma, Inc. · NASDAQ:CBIO
Brumm Joshua T sold 9,447 Crescent Biopharma, Inc. shares (Form 4)
Traded Sep 16 to Sep 18, 2026 · Filed Sep 18, 2026
From Sep 16 to Sep 18, 2026, Brumm Joshua T (Director, Chief Executive Officer) sold 9,447 Crescent Biopharma, Inc. shares at an average US$16.91 for US$160K under a trading plan, leaving 271,765 shares. Filed Sep 18, 2026 (Form 4).
- Sold
- 9,447 shares
- Price
- US$16.91 average (US$16.71 to US$17.90)
- Value
- US$160K
- Holding after
- 271,765 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Ordinary Shares | Sale | 1,610 | US$17.90 | 279,602 | Direct |
| Sep 18, 2026 | Ordinary Shares | Sale | 7,837 | US$16.71 | 271,765 | Direct |
Source
Related
- Crescent Biopharma, Inc.
- Brumm Joshua T
- Crescent Biopharma, Inc. shareholders
- Form 4 · Brumm Joshua T · Jun 23, 2026
- Form 4 · McNeill Jonathan · Sep 18, 2026
- Form 4 · Lynch Ryan · Sep 18, 2026
- Form 4 · Pinkas Jan · Sep 18, 2026
- Form 4 · Im Ellie Eunkyung · Sep 18, 2026
- Form 4 · Scalzo Richard William · Sep 18, 2026